Your browser doesn't support javascript.
loading
Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
Gerardi, Savannah; Sperlea, David; Levy, Shirel Ora-Lee; Bondurant-David, Kaitlin; Dang, Sébastien; David, Pierre-Marie; Lizotte, Annie; Senécal, Lysane; Paquette, François; Vanier, Marie-Claude.
Afiliação
  • Gerardi S; Département de Pharmacie, CISSS de Laval, Laval, QC, Canada.
  • Sperlea D; Département de Pharmacie, CIUSSS du Centre-Ouest-de-l'Île-de-Montréal, Montréal, QC, Canada.
  • Levy SO; Département de Pharmacie, CIUSSS du Nord-de-l'Île-de-Montréal, Montréal, QC, Canada.
  • Bondurant-David K; Département de Pharmacie, CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montréal, QC, Canada.
  • Dang S; Département de Pharmacie, CIUSSS de la Mauricie-et-du-Centre-du-Québec, Trois-Rivières, QC, Canada.
  • David PM; Faculté de Pharmacie, Université de Montréal, Montréal, QC, Canada.
  • Lizotte A; Département de Pharmacie, CISSS de Laval, Laval, QC, Canada.
  • Senécal L; Département de Pharmacie, CISSS de Laval, Laval, QC, Canada.
  • Paquette F; Département de Néphrologie, CISSS de Laval, Laval, QC, Canada.
  • Vanier MC; Faculté de Pharmacie, Université de Montréal, Montréal, QC.
Am J Health Syst Pharm ; 79(Suppl 4): S128-S135, 2022 11 22.
Article em En | MEDLINE | ID: mdl-35881917
ABSTRACT

PURPOSE:

Patients on hemodialysis have a high risk of medication-related problems. Studies using deprescribing algorithms to reduce the number of inappropriate medications in this population have been published, but none have used a patient-partnership approach. Our study evaluated the impact of a similar intervention with a patient-partnership approach.

METHODS:

The objective was to describe the implementation of a pharmacist-led intervention with a patient-partnership approach using deprescribing algorithms and its impact on the reduction of inappropriate medications in patients on hemodialysis. Eight algorithms were developed by pharmacists and nephrologists to assess the appropriateness of medications. Pharmacists identified patients taking targeted medications. Following patient enrollment, pharmacists assessed medications with patients and applied the algorithms. With patient consent, deprescription was suggested to nephrologists if applicable. Specific data on each targeted medication were collected at 4 and 16 weeks. Descriptive statistics were used to examine the effects of the deprescribing intervention.

RESULTS:

Of 270 patients, 256 were taking at least one targeted medication. Of the 122 patients taking at least one targeted medication who were approached to participate, 66 were included in the study. At enrollment, these patients were taking 252 targeted medications, of which 59 (23.4%) were determined to be inappropriate. Deprescription was initiated for 35 of these 59 medications (59.3%). At 4 weeks, 33 of the 59 medications (55.9%) were still deprescribed, while, at 16 weeks, 27 of the 59 medications (45.8%) were still deprescribed. Proton pump inhibitors and benzodiazepines or Z-drugs were the most common inappropriate medications, and allopurinol was the most deprescribed medication.

CONCLUSION:

A pharmacist-led intervention with a patient-partnership approach and using deprescribing algorithms reduced the number of inappropriate medications in patients on hemodialysis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desprescrições / Lista de Medicamentos Potencialmente Inapropriados Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Health Syst Pharm Assunto da revista: FARMACIA / HOSPITAIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desprescrições / Lista de Medicamentos Potencialmente Inapropriados Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Health Syst Pharm Assunto da revista: FARMACIA / HOSPITAIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá